Chatham House, February 9-10


Monday, November 12, 2007

Biotechnology Conference Schedule: October 2008

Organizer Conference Name Month Start Date End Date Days Location
ACS 64th Southwest Regional Meeting October 10/1/2008 10/4/2008 4 Little Rock, Arkansas
BMES 2008 BMES Annual Fall Meeting  October 10/1/2008 10/4/2008 4 St. Loius, MO
ACR ACRIN Biannual Meeting October 10/2/2008 10/5/2008 4 Arlington, VA
GTCbio Tumor Progression & Therapeutic Resistance (5th Annual) October 10/6/2008 10/7/2008 2 San Francisco, CA
IBS  13th International Biotechnology Symposium & Exhibition (IBS-2008) October 10/12/2008 10/17/2008 6 Dalian, China
SBS SFN 2008 October 10/14/2008 10/18/2008 5 Atlanta, GA
GTCbio Biomarkers Europe October 10/16/2008 10/17/2008 2 Dublin, Ireland
ACCP American College of Clinical Pharmacy Annual meeting  October 10/19/2008 10/22/2008 4 Louisville, KY
Lisencing Exeutives Society LES Annual meeting October 10/19/2008 10/23/2008 5 Orlando, FL
EORTC Euro Organization for Research & Treatment of Cancer October 10/21/2008 10/24/2008 4 Switzerland, Europe
FECS / ECCO 20th EORTC-NCI-AACR Symposium on Molecular Targets & Cancer Therapeutics October 10/21/2008 10/24/2008 4 Geneva , Switzerland
GTCbio Modern Drug Discovery & Development October 10/27/2008 10/29/2008 3 San Diego, CA

1 comments:

D.Immaculate said...

Webinar Title: Analysis of Oligonucleotides as Biotherapeutics

Date: October 2, 2008

Time: 1:00-2:00 EDT

Web Address: www.genengnews.com/oligos

Contact: Joan Boyce at jboyce@genengnews.com

Description:

Interest in therapeutic oligos has created demand for methods and instruments for analyzing these molecular classes. This webinar will present the latest techniques for identifying, characterizing, and quantifying important classes of oligonucleotide drugs including antisense phosphorothioates, RNAi agents, oligonucleotide aptamers, and PEGylated oligos.

Key learning points for this webinar:

§ The capabilities and limitations of oligonucleotide analytic platforms

§ How to transfer an analytical method from bench to development and production

§ Analyzing oligonucleotides in complex biological samples

§ Advances in HPLC and LC/MS techniques that can shorten analysis times

§ Regulatory and validation aspects of oligonucleotide analysis

Your hosts for this webinar, Ipsita Roymoulik, Ph.D. (Avecia Biotechnology), Yansheng Wu, Ph.D. (Archemix), and Martin Gilar, Ph.D. (Waters Corporation), will detail, through their presentations, specific, unique analytic requirements of oligonucleotides when used as therapeutic molecules. A live Q&A session will follow the presentations, offering you a chance to pose questions to our expert panelists.